Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiotis D Kottaridis

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|May 10, 2002
Development of squamous cell carcinoma of the skin during induction chemotherapy for acute myeloid leukemiaPanagiotis D Kottaridis, Anthony H Goldstone
Leukemia & Lymphoma|June 19, 2004
The allogeneic effect in non-Hodgkin's lymphomaAnthony H Goldstone, Panagiotis D Kottaridis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Cavernosal arterial insufficiency and metabolic syndrome probably represent a common pathology of endothelial dysfunction in recipients of high-dose therapy and stem-cell transplantationRatna Chatterjee, Katerina Palla, Panagiotis D Kottaridis
British Journal of Haematology|August 6, 2003
Flt3 mutations and leukaemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
Leukemia & Lymphoma|July 12, 2003
Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
British Journal of Haematology|April 29, 2006
Diffuse bowel fluorodeoxyglucose uptake on positron emission tomography scan following allogeneic stem cell transplantWendy A Stewart, Jamshed B Bomanji, Stephen Mackinnon, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Reduced intensity transplantation: where are we now?Stephen Mackinnon, Kirsty Thomson, Emma Morris, et al.
British Journal of Haematology|July 2, 2020
Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemicNadine Farah, Richard Burt, Amr R Ibrahim, et al.
Transplantation|September 8, 2012
Preservation of fertility in women undergoing reduced-intensity conditioning allogeneic transplantation with a fludarabine-based regimeSotirios G Papageorgiou, Osman Ahmed, Nitish Narvekar, et al.
British Journal of Haematology|May 22, 2020
Interleukin-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvementJames W Day, Thomas A Fox, Richard Halsey, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|May 10, 2002
Development of squamous cell carcinoma of the skin during induction chemotherapy for acute myeloid leukemiaPanagiotis D Kottaridis, Anthony H Goldstone
Leukemia & Lymphoma|June 19, 2004
The allogeneic effect in non-Hodgkin's lymphomaAnthony H Goldstone, Panagiotis D Kottaridis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Cavernosal arterial insufficiency and metabolic syndrome probably represent a common pathology of endothelial dysfunction in recipients of high-dose therapy and stem-cell transplantationRatna Chatterjee, Katerina Palla, Panagiotis D Kottaridis
British Journal of Haematology|August 6, 2003
Flt3 mutations and leukaemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
Leukemia & Lymphoma|July 12, 2003
Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
British Journal of Haematology|April 29, 2006
Diffuse bowel fluorodeoxyglucose uptake on positron emission tomography scan following allogeneic stem cell transplantWendy A Stewart, Jamshed B Bomanji, Stephen Mackinnon, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Reduced intensity transplantation: where are we now?Stephen Mackinnon, Kirsty Thomson, Emma Morris, et al.
British Journal of Haematology|July 2, 2020
Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemicNadine Farah, Richard Burt, Amr R Ibrahim, et al.
Transplantation|September 8, 2012
Preservation of fertility in women undergoing reduced-intensity conditioning allogeneic transplantation with a fludarabine-based regimeSotirios G Papageorgiou, Osman Ahmed, Nitish Narvekar, et al.
British Journal of Haematology|May 22, 2020
Interleukin-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvementJames W Day, Thomas A Fox, Richard Halsey, et al.
Pageof 3